EU promises speedy review of remdesivir

The European health regulator has vowed to conduct a speedy review of Gilead Sciences' potential COVID-19 drug, remdesivir, but says it has not yet received an application from the US drugmaker.

from Breaking News | Daily Telegraph https://ift.tt/3dfAW2l
https://ift.tt/eA8V8J